Manual of I.V. Therapeutics, 4th Edition

(2)
Manual of I.V. Therapeutics, 4th Edition image
ISBN-10:

0803611870

ISBN-13:

9780803611870

Author(s): Phillips, Lynn
Edition: 4th
Released: Jan 24, 2005
Format: Paperback, 812 pages

Description:

Manual of I.V. Therapeutics, 4th Edition, is a self-paced book designed to help the student, novice, or advanced practitioner in any setting where infusion-related skills are necessary. This new edition continues to emphasize standards of practice using the guidelines of the Occupational Safety and Health Administration (OSHA), Intravenous Nursing Society (INS) and Centers for Disease Control and Prevention (CDC). To help your students prepare for the CRNI exam, we include a CD-ROM with 400 multiple-choice review questions with answers and rationales.

Best prices to buy, sell, or rent ISBN 9780803611870




Related Books

Frequently Asked Questions about Manual of I.V. Therapeutics, 4th Edition

You can buy the Manual of I.V. Therapeutics, 4th Edition book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $6.78 on Amazon and is available from 20 sellers at the moment.

At BookScouter, the prices for the book start at $3.18. Feel free to explore the offers for the book in used or new condition from various booksellers, aggregated on our website.

If you’re interested in selling back the Manual of I.V. Therapeutics, 4th Edition book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Manual of I.V. Therapeutics, 4th Edition book, the best buyback offer comes from and is $ for the book in good condition.

The Manual of I.V. Therapeutics, 4th Edition book is in very low demand now as the rank for the book is 4,772,043 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.